Cargando…

Assessment of temporally-related acute respiratory illness following influenza vaccination

BACKGROUND: A barrier to influenza vaccination is the misperception that the inactivated vaccine can cause influenza. Previous studies have investigated the risk of acute respiratory illness (ARI) after influenza vaccination with conflicting results. We assessed whether there is an increased rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rikin, Sharon, Jia, Haomiao, Vargas, Celibell Y., Castellanos de Belliard, Yaritza, Reed, Carrie, LaRussa, Philip, Larson, Elaine L., Saiman, Lisa, Stockwell, Melissa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115556/
https://www.ncbi.nlm.nih.gov/pubmed/29525279
http://dx.doi.org/10.1016/j.vaccine.2018.02.105
_version_ 1783514123184635904
author Rikin, Sharon
Jia, Haomiao
Vargas, Celibell Y.
Castellanos de Belliard, Yaritza
Reed, Carrie
LaRussa, Philip
Larson, Elaine L.
Saiman, Lisa
Stockwell, Melissa S.
author_facet Rikin, Sharon
Jia, Haomiao
Vargas, Celibell Y.
Castellanos de Belliard, Yaritza
Reed, Carrie
LaRussa, Philip
Larson, Elaine L.
Saiman, Lisa
Stockwell, Melissa S.
author_sort Rikin, Sharon
collection PubMed
description BACKGROUND: A barrier to influenza vaccination is the misperception that the inactivated vaccine can cause influenza. Previous studies have investigated the risk of acute respiratory illness (ARI) after influenza vaccination with conflicting results. We assessed whether there is an increased rate of laboratory-confirmed ARI in post-influenza vaccination periods. METHODS: We conducted a cohort sub-analysis of children and adults in the MoSAIC community surveillance study from 2013 to 2016. Influenza vaccination was confirmed through city or hospital registries. Cases of ARI were ascertained by twice-weekly text messages to household to identify members with ARI symptoms. Nasal swabs were obtained from ill participants and analyzed for respiratory pathogens using multiplex PCR. The primary outcome measure was the hazard ratio of laboratory-confirmed ARI in individuals post-vaccination compared to other time periods during three influenza seasons. RESULTS: Of the 999 participants, 68.8% were children, 30.2% were adults. Each study season, approximately half received influenza vaccine and one third experienced ≥1 ARI. The hazard of influenza in individuals during the 14-day post-vaccination period was similar to unvaccinated individuals during the same period (HR 0.96, 95% CI [0.60, 1.52]). The hazard of non-influenza respiratory pathogens was higher during the same period (HR 1.65, 95% CI [1.14, 2.38]); when stratified by age the hazard remained higher for children (HR 1·71, 95% CI [1.16, 2.53]) but not for adults (HR 0.88, 95% CI [0.21, 3.69]). CONCLUSION: Among children there was an increase in the hazard of ARI caused by non-influenza respiratory pathogens post-influenza vaccination compared to unvaccinated children during the same period. Potential mechanisms for this association warrant further investigation. Future research could investigate whether medical decision-making surrounding influenza vaccination may be improved by acknowledging patient experiences, counseling regarding different types of ARI, and correcting the misperception that all ARI occurring after vaccination are caused by influenza.
format Online
Article
Text
id pubmed-7115556
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71155562020-04-02 Assessment of temporally-related acute respiratory illness following influenza vaccination Rikin, Sharon Jia, Haomiao Vargas, Celibell Y. Castellanos de Belliard, Yaritza Reed, Carrie LaRussa, Philip Larson, Elaine L. Saiman, Lisa Stockwell, Melissa S. Vaccine Article BACKGROUND: A barrier to influenza vaccination is the misperception that the inactivated vaccine can cause influenza. Previous studies have investigated the risk of acute respiratory illness (ARI) after influenza vaccination with conflicting results. We assessed whether there is an increased rate of laboratory-confirmed ARI in post-influenza vaccination periods. METHODS: We conducted a cohort sub-analysis of children and adults in the MoSAIC community surveillance study from 2013 to 2016. Influenza vaccination was confirmed through city or hospital registries. Cases of ARI were ascertained by twice-weekly text messages to household to identify members with ARI symptoms. Nasal swabs were obtained from ill participants and analyzed for respiratory pathogens using multiplex PCR. The primary outcome measure was the hazard ratio of laboratory-confirmed ARI in individuals post-vaccination compared to other time periods during three influenza seasons. RESULTS: Of the 999 participants, 68.8% were children, 30.2% were adults. Each study season, approximately half received influenza vaccine and one third experienced ≥1 ARI. The hazard of influenza in individuals during the 14-day post-vaccination period was similar to unvaccinated individuals during the same period (HR 0.96, 95% CI [0.60, 1.52]). The hazard of non-influenza respiratory pathogens was higher during the same period (HR 1.65, 95% CI [1.14, 2.38]); when stratified by age the hazard remained higher for children (HR 1·71, 95% CI [1.16, 2.53]) but not for adults (HR 0.88, 95% CI [0.21, 3.69]). CONCLUSION: Among children there was an increase in the hazard of ARI caused by non-influenza respiratory pathogens post-influenza vaccination compared to unvaccinated children during the same period. Potential mechanisms for this association warrant further investigation. Future research could investigate whether medical decision-making surrounding influenza vaccination may be improved by acknowledging patient experiences, counseling regarding different types of ARI, and correcting the misperception that all ARI occurring after vaccination are caused by influenza. Elsevier Ltd. 2018-04-05 2018-03-07 /pmc/articles/PMC7115556/ /pubmed/29525279 http://dx.doi.org/10.1016/j.vaccine.2018.02.105 Text en © 2018 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rikin, Sharon
Jia, Haomiao
Vargas, Celibell Y.
Castellanos de Belliard, Yaritza
Reed, Carrie
LaRussa, Philip
Larson, Elaine L.
Saiman, Lisa
Stockwell, Melissa S.
Assessment of temporally-related acute respiratory illness following influenza vaccination
title Assessment of temporally-related acute respiratory illness following influenza vaccination
title_full Assessment of temporally-related acute respiratory illness following influenza vaccination
title_fullStr Assessment of temporally-related acute respiratory illness following influenza vaccination
title_full_unstemmed Assessment of temporally-related acute respiratory illness following influenza vaccination
title_short Assessment of temporally-related acute respiratory illness following influenza vaccination
title_sort assessment of temporally-related acute respiratory illness following influenza vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115556/
https://www.ncbi.nlm.nih.gov/pubmed/29525279
http://dx.doi.org/10.1016/j.vaccine.2018.02.105
work_keys_str_mv AT rikinsharon assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT jiahaomiao assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT vargascelibelly assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT castellanosdebelliardyaritza assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT reedcarrie assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT larussaphilip assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT larsonelainel assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT saimanlisa assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination
AT stockwellmelissas assessmentoftemporallyrelatedacuterespiratoryillnessfollowinginfluenzavaccination